Certified by Founder Lodge
SynOx Therapeutics

START UP
1 Disclosed Funding Rounds $75,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications.
Date | Round | Raised | Participating Investors |
---|---|---|---|
April, 23 ,2024 | Series B | $75,000,000 |